ストックスクリーナーアプリを入手
8.06
1.59%
-0.13
アフターアワーズ：
8.06
前日終値:
$8.19
開ける：
$8.14
24時間の取引高:
2.66M
Relative Volume:
1.10
時価総額：
$1.04B
収益：
$628.25M
当期純損益:
$-78.55M
株価収益率:
-13.00
EPS:
-0.62
ネットキャッシュフロー:
$-29.73M
1週間 パフォーマンス:
+11.79%
1か月 パフォーマンス:
+42.15%
6か月 パフォーマンス:
-13.70%
1年 パフォーマンス:
-48.70%
1日の値動き範囲:
$7.84
$8.18
1週間の範囲:
$7.84
$9.06
52週間の値動き範囲:
$4.72
$19.11
Neogenomics Inc Stock (NEO) Company Profile
NEO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
8.06 | 1.14B | 628.25M | -78.55M | -29.73M | -0.62 |
|
TMO
Thermo Fisher Scientific Inc
|
489.49 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
199.03 | 145.92B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
640.44 | 51.16B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
128.48 | 35.50B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
184.08 | 31.24B | 15.70B | 1.24B | 2.01B | 6.91 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-30 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-07-29 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-05-15 | 開始されました | Guggenheim | Neutral |
| 2025-04-30 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2025-01-13 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2024-12-10 | 開始されました | Jefferies | Buy |
| 2024-05-01 | 再開されました | Craig Hallum | Buy |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-08-21 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-02-24 | アップグレード | The Benchmark Company | Hold → Buy |
| 2023-02-01 | アップグレード | Needham | Hold → Buy |
| 2022-08-26 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-22 | ダウングレード | Needham | Buy → Hold |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-03-29 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-03-29 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | 再開されました | Stephens | Overweight |
| 2021-12-16 | 開始されました | Cowen | Outperform |
| 2021-11-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-02-25 | 再開されました | Needham | Buy |
| 2021-02-25 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-12-11 | 再開されました | BTIG Research | Buy |
| 2020-10-28 | 繰り返されました | Needham | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-28 | 開始されました | Guggenheim | Buy |
| 2020-07-29 | 繰り返されました | Needham | Buy |
| 2020-06-25 | 開始されました | BofA/Merrill | Buy |
| 2020-04-21 | 再開されました | Stephens | Overweight |
| 2020-03-02 | 再開されました | Craig Hallum | Buy |
| 2020-02-28 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | ダウングレード | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-05-01 | 繰り返されました | Needham | Buy |
| 2019-03-29 | 繰り返されました | Needham | Buy |
| 2019-01-03 | 開始されました | Needham | Buy |
| 2018-10-24 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | 開始されました | Leerink Partners | Outperform |
| 2018-05-02 | ダウングレード | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2017-08-24 | 開始されました | Gabelli & Co | Buy |
| 2016-12-15 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Neogenomics Inc (NEO) 最新ニュース
Will NeoGenomics Inc. benefit from geopolitical trends2025 Biggest Moves & Precise Trade Entry Recommendations - khodrobank.com
Brown Advisory Small-Cap Growth Strategy Sold Neogenomics (NEO) Following the News of CEO Departure - MSN
What is NeoGenomics Inc. s revenue forecastJuly 2025 Levels & Daily Chart Pattern Signal Reports - khodrobank.com
How to manage a losing position in NeoGenomics Inc.Portfolio Growth Summary & Consistent Return Investment Signals - Newser
Natera (NTRA) Provides an Update on its Intellectual Property Litigation With NeoGenomics - MSN
How moving averages guide NeoGenomics Inc. tradingJuly 2025 Breakouts & Verified Chart Pattern Signals - Newser
Is NeoGenomics Inc. stock a value trapQuarterly Profit Report & Smart Swing Trading Alerts - khodrobank.com
Fed Meeting: How does NeoGenomics Inc. perform in inflationary periodsMarket Performance Recap & Long Hold Capital Preservation Plans - khodrobank.com
NeoGenomics (NASDAQ:NEO) Is Making Moderate Use Of Debt - 富途牛牛
Liquid Biopsy in Cancer Diagnostics Market to Witness Robust ~17% CAGR Expansion by 2032 | DelveInsight - Barchart.com
Is now a turning point for NeoGenomics Inc.July 2025 Trade Ideas & Smart Swing Trading Techniques - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc.NEO - PR Newswire
What are NeoGenomics Inc.’s recent SEC filings showingExit Point & Technical Pattern Alert System - khodrobank.com
Applying big data sentiment scoring on NeoGenomics Inc.Analyst Downgrade & Risk Managed Investment Signals - Newser
Real time social sentiment graph for NeoGenomics Inc.Weekly Profit Report & High Return Trade Guides - Newser
Has NeoGenomics Inc. found a price floorQuarterly Earnings Summary & Free Accurate Trade Setup Notifications - Newser
What data driven models say about NeoGenomics Inc.’s futureMarket Trend Review & Safe Swing Trade Setup Alerts - Newser
Should I trade or invest in NeoGenomics Inc.Market Trend Summary & Free Weekly Chart Analysis and Trade Guides - khodrobank.com
Ranking NeoGenomics Inc. among high performing stocks via toolsGap Down & Free Long-Term Investment Growth Plans - Newser
Using Python tools to backtest NeoGenomics Inc. strategiesQuarterly Trade Report & Precise Trade Entry Recommendations - Newser
What’s next for NeoGenomics Inc. stock priceGDP Growth & Pattern Based Trade Signal System - Newser
When is the best time to exit NeoGenomics Inc.July 2025 Market Mood & Fast Exit and Entry Strategy Plans - Newser
Signal strength of NeoGenomics Inc. stock in tech scannersJuly 2025 Closing Moves & Verified Momentum Stock Ideas - Newser
Is NeoGenomics Inc. meeting your algorithmic filter criteriaJuly 2025 Review & Technical Pattern Recognition Alerts - Newser
Can momentum traders help lift NeoGenomics Inc.Earnings Recap Summary & Fast Entry Momentum Trade Alerts - Newser
Does NeoGenomics Inc. qualify in momentum factor screeningPrice Action & Precise Trade Entry Recommendations - Newser
Chart based analysis of NeoGenomics Inc. trendsTrend Reversal & AI Forecast Swing Trade Picks - Newser
Does NeoGenomics Inc. have a sustainable dividendTrade Analysis Report & Risk Managed Investment Strategies - khodrobank.com
Applying sector rotation models to NeoGenomics Inc.July 2025 EndofMonth & Risk Adjusted Buy and Sell Alerts - Newser
What is NeoGenomics Inc. s debt to equity ratioJuly 2025 PostEarnings & High Win Rate Trade Tips - khodrobank.com
Is now a turning point for NeoGenomics IncIndex Update & Technical Pattern Based Buy Signals - Newser
NeoGenomics reports Q2 revenue of $181.3mln, net loss of $45.1mln. - AInvest
Fort Myers cancer lab firm wins federal patent lawsuit - Business Observer
Neogenomics stock price target raised to $11 from $6.50 at Stephens - Investing.com Canada
Neogenomics shares fall 1.25% premarket after court rules in favor of patent invalidity. - AInvest
Does NeoGenomics Inc. meet Warren Buffett’s criteriaTrade Risk Summary & Daily Oversold Stock Bounce Ideas - khodrobank.com
Will NeoGenomics Inc. outperform the market in YEARVolume Spike & Daily Chart Pattern Signals - khodrobank.com
Why is NeoGenomics Inc. stock going upCPI Data & Fast Entry Momentum Trade Alerts - khodrobank.com
Technical Charts Suggest Momentum Shift in CCRN getLinesFromResByArray error: size == 0 - kangso.co.kr
Full technical analysis of NeoGenomics Inc. stockJuly 2025 Market Mood & Long-Term Safe Investment Ideas - Newser
NeoGenomics rallies after court win in Natera patent dispute - MSN
Applying big data sentiment scoring on NeoGenomics IncWeekly Trade Recap & High Conviction Investment Ideas - Newser
Neogenomics Soars 21.64% on Legal Victory, Cancer Diagnostics Dominance - AInvest
Is a relief rally coming for NeoGenomics Inc. holdersJuly 2025 Outlook & Growth Oriented Trade Recommendations - Newser
Can NeoGenomics Inc. deliver consistent EPS growthMarket Performance Recap & Long-Term Safe Investment Plans - khodrobank.com
How to interpret RSI for NeoGenomics Inc. stockMarket Volume Report & Free High Accuracy Swing Entry Alerts - Newser
Can NeoGenomics Inc. rally from current levelsEarnings Growth Report & Safe Entry Zone Identification - Newser
Has NeoGenomics Inc. formed a bullish divergenceGap Down & Weekly Setup with High ROI Potential - Newser
Automated trading signals detected on NeoGenomics Inc.July 2025 Trends & Consistent Profit Trade Alerts - Newser
Analysts Backtest Strategies on NeoGenomics Inc. With Promising Results getLinesFromResByArray error: size == 0 - 더경남뉴스
NeoGenomics Sees Price Target Reduced Amidst Steady Optimism - StocksToTrade
Neogenomics Inc (NEO) 財務データ
収益
当期純利益
現金流量
EPS
Neogenomics Inc (NEO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Zook Anthony P. | Chief Executive Officer |
Aug 06 '25 |
Buy |
5.58 |
17,900 |
99,954 |
38,066 |
| Williams Felicia | Director |
Jun 01 '25 |
Option Exercise |
0.00 |
7,160 |
0 |
7,160 |
| KANOVSKY STEPHEN M | Director |
Jun 01 '25 |
Option Exercise |
0.00 |
12,254 |
0 |
52,344 |
| Kelly Michael Aaron | Director |
Jun 01 '25 |
Option Exercise |
0.00 |
12,254 |
0 |
44,009 |
| TETRAULT LYNN A. | Director |
Jun 01 '25 |
Option Exercise |
0.00 |
12,254 |
0 |
73,652 |
| Floegel Elizabeth | Director |
Jun 01 '25 |
Option Exercise |
0.00 |
12,254 |
0 |
23,590 |
| Gunn Neil | Director |
Jun 01 '25 |
Option Exercise |
0.00 |
12,254 |
0 |
28,100 |
| Zook Anthony P. | Chief Executive Officer |
Jun 01 '25 |
Option Exercise |
0.00 |
12,254 |
0 |
23,590 |
| Perez David Brian | Director |
Jun 01 '25 |
Option Exercise |
0.00 |
12,254 |
0 |
33,890 |
| Kelly Michael Aaron | Director |
May 27 '25 |
Buy |
7.60 |
5,000 |
38,000 |
5,000 |
3.32%
0.58%
大文字化:
|
ボリューム (24 時間):